Average Co-Inventor Count = 3.55
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cornell University (20 from 2,886 patents)
2. Tri-Institutional Therapeutics Discovery Institute (3 from 8 patents)
3. Merck + Co., Inc. (2 from 4,770 patents)
4. The Rockefeller University (2 from 712 patents)
5. Other (1 from 832,912 patents)
6. University of Kansas (1 from 548 patents)
23 patents:
1. 12473331 - Macrocyclic compounds as proteasome inhibitors
2. 12016896 - Dipeptidomimetics as inhibitors of human immunoproteasomes
3. RE49816 - Dipeptides as inhibitors of human immunoproteasomes
4. 11834515 - Macrocyclic compounds as proteasome inhibitors
5. 11732005 - Peptidomimetic proteasome inhibitors
6. 11629141 - Proteasome inhibitors and uses thereof
7. 11202817 - Dipeptidomimetics as inhibitors of human immunoproteasomes
8. 11203613 - Peptidomimetic proteasome inhibitors
9. 11066397 - Proteasome inhibitors and uses thereof
10. 10059722 - Cephalosporin derivatives and methods of use
11. 9988421 - Dipeptides as inhibitors of human immunoproteasomes
12. 8951992 - [object Object]
13. 8338465 - Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
14. 7977366 - Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation
15. 7427595 - Use of proepithelin to promote wound repair and reduce inflammation